Open AccessNew Combinations of Cytotoxic Agents for Non-Small Cell Lung Cancer
Author(s) -
Naiyer A. Rizvi
Publication year - 2000
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000055069
Subject(s) - cytotoxic t cell , lung cancer , medicine , cancer research , oncology , biology , genetics , in vitro
Taxanes and platinum derivatives are emerging as an important combination in the treatment of non-small cell lung cancer (NSCLC). The use of paclitaxel plus carboplatin has been received much attention in recent years, and there is now increasing interest in combinations of docetaxel and platinum derivatives. Recent attention has also focussed on the development of non-platinum combinations for the treatment of NSCLC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom